WebBiocon Limited is an Indian public company incorporated on 29/11/1978 and its registered office address is 20TH K.M.HOSUR ROAD,HEBBAGODI,Bangalore,Karnataka,INDIA,561229. The company's Annual General Meeting (AGM) was last held on 2015-07-24 and its balance sheet was last filed on 2015 … WebMar 28, 2024 · CONTACT +91 80 2808 2808 . [email protected] . About Us. Overview; Who we are; ... 28-Mar-2024 Details . Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research …
Contact Us - Enquiry / Information regarding our businesses - Biocon
WebMay 25, 2024 · Biocon Electric Private Limited is a 3 years 5 months old, private Indian Company, registered at Bangalore with a paid-up capital of Rs.50000000.0. ... Contact Details of Biocon Electric Private Limited. Biocon Electric Private Limited. Location. Bangalore, Karnataka, India. Website. bioconelectric.in. Telephone. Email Address. View … WebBiocon Limited 20th KM, Hosur Road, Electronic City, Bengaluru 560100, Karnataka, India CIN: L24234KA1978PLC003417 T +91 80 2808 2808 / +91 80 4014 4014 F +91 80 2852 … Find all our global overseas offices corporate contact details for any enquiry … CONTACT +91 80 2808 2808 . [email protected] . About Us ... Mr … CONTACT +91 80 2808 2808 . [email protected] . About Us. Overview; … Syngene started as India’s first Contract Research Organisation (CRO) in early … Biocon’s Board of Directors comprises qualified personnel who possess … crystalking99
Biocon > Location Details > Pharmaceuticals > Location Details …
WebThe contact details of the company are mentioned in the contact section or you could contact them by submitting the request for quote form on their website. Biocon Biologics India Limited is a manufacturer company with the … WebBiocon Limited is an Indian biopharmaceutical company based in Bangalore.It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active … WebApr 12, 2024 · Limited data on the effect of hepatic impairment (including Child-Pugh C classification of chronic liver disease) on the pharmacokinetics of posaconazole demonstrate an increase in plasma exposure compared to subjects with normal hepatic function, but do not suggest that dose adjustment is necessary (see sections 4.4 and 5.2). dwight price facebook